Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AerovectRx, Corp.
AerovectRx receives U.S. FDA 510(k) clearance for nebulizer drug delivery system
May 8th, 2006
AerovectRx, Corp., developers of new pain-free, inhaled drug delivery technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration to market the first vibrating mesh nebulizer with a disposable medication cartridge. The new technology is planned for use to deliver a wide variety of specialty point-of-care therapies painlessly by inhalation rather than injections. "Our unique, painless technology platform provides fast and easy delivery of a wide range of therapies and vaccines providing access to multi-billion dollar market opportunities including influenza, idiopathic pulmonary fibrosis and diabetes," said...
Source: Biotech Week (2006-05-08)
|
